FDA approves Restylane products for treating nasolabial folds

Galderma announced it has received FDA approval of two new Restylane products for the treatment of nasolabial folds in patients over the age of 21.The agency approved Restylane Refyne for moderate-to-severe facial wrinkles and folds and Restylane Defyne for treating moderate-to-severe, deep facial wrinkles and folds. The gels have been shown to maintain effectiveness for treating nasolabial folds for up to 12 months and are manufactured with XpresHAn technology, which customizes the degree of hyaluronic acid crosslinking in each product to allow a range of flexibly and support, according to (Read more...)

Full Story →